- Home
- HOWL vs KNDI Comparison
HOWL vs KNDI Comparison
Compare HOWL & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- KNDI
- Stock Information
- Founded
- HOWL 2017
- KNDI 2002
- Country
- HOWL United States
- KNDI China
- Employees
- HOWL N/A
- KNDI N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- KNDI Auto Manufacturing
- Sector
- HOWL Health Care
- KNDI Consumer Discretionary
- Exchange
- HOWL Nasdaq
- KNDI Nasdaq
- Market Cap
- HOWL 47.1M
- KNDI 96.3M
- IPO Year
- HOWL 2021
- KNDI N/A
- Fundamental
- Price
- HOWL $1.41
- KNDI $1.27
- Analyst Decision
- HOWL Strong Buy
- KNDI
- Analyst Count
- HOWL 3
- KNDI 0
- Target Price
- HOWL $8.33
- KNDI N/A
- AVG Volume (30 Days)
- HOWL 569.8K
- KNDI 134.9K
- Earning Date
- HOWL 08-07-2025
- KNDI 08-15-2025
- Dividend Yield
- HOWL N/A
- KNDI N/A
- EPS Growth
- HOWL N/A
- KNDI N/A
- EPS
- HOWL N/A
- KNDI N/A
- Revenue
- HOWL $1,143,000.00
- KNDI $127,569,613.00
- Revenue This Year
- HOWL N/A
- KNDI N/A
- Revenue Next Year
- HOWL N/A
- KNDI N/A
- P/E Ratio
- HOWL N/A
- KNDI N/A
- Revenue Growth
- HOWL N/A
- KNDI 3.21
- 52 Week Low
- HOWL $0.60
- KNDI $0.89
- 52 Week High
- HOWL $4.18
- KNDI $2.07
- Technical
- Relative Strength Index (RSI)
- HOWL 66.52
- KNDI 63.81
- Support Level
- HOWL $1.25
- KNDI $1.09
- Resistance Level
- HOWL $1.50
- KNDI $1.30
- Average True Range (ATR)
- HOWL 0.08
- KNDI 0.06
- MACD
- HOWL 0.03
- KNDI 0.01
- Stochastic Oscillator
- HOWL 79.38
- KNDI 86.36
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.